We are live on ! Find out more
HAE icon

Haemonetics
HAE

207 hedge funds and large institutions have $2.46B invested in Haemonetics in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 77 increasing their positions, 72 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 17

12% more capital invested

Capital invested by funds: $2.19B → $2.46B (+$268M)

5% more funds holding

Funds holding: 197 → 207 (+10)

7% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 72

1.52% less ownership

Funds ownership: 105.66% → 104.14% (-1.5%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
207
Holders Change
+10
Holders Change %
+5.08%
% of All Funds
5.16%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
30
Increased
77
Reduced
72
Closed
17
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
+$2K

Top Buyers

1
Victory Capital Management
Victory Capital Management
Texas
+$15.8M
2
NC
Nitorum Capital
New York
+$10.4M
3
Bank of America
Bank of America
North Carolina
+$8.34M
4
BlackRock
BlackRock
New York
+$7.9M
5
Neuberger Berman Group
Neuberger Berman Group
New York
+$7.89M

Top Sellers

1
BCIM
Black Creek Investment Management
Ontario, Canada
-$32.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$26M
3
HM
HealthCor Management
New York
-$16.7M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$16.2M
5
Morgan Stanley
Morgan Stanley
New York
-$9.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
MSA
126
Mason Street Advisors
Wisconsin
$598K +$16K +385 +3%
LCM
127
Legato Capital Management
California
$593K – – –
Stifel Financial
128
Stifel Financial
Missouri
$574K +$36K +867 +7%
Two Sigma Investments
129
Two Sigma Investments
New York
$558K +$517K +12,444 New
RE
130
RBC Europe
United Kingdom
$515K +$477K +11,469 New
PIA
131
Piedmont Investment Advisors
North Carolina
$514K +$4.78K +115 +1%
CI
132
Cigna Investments
Connecticut
$489K -$1.7K -41 -0.4%
AG
133
Aperio Group
California
$479K -$1.04K -25 -0.2%
NSAM
134
North Star Asset Management
Wisconsin
$473K -$516K -12,410 -54%
SCM
135
Stevens Capital Management
Pennsylvania
$470K -$717K -17,264 -62%
SOADOR
136
State of Alaska Department of Revenue
Alaska
$467K +$2.49K +60 +0.6%
TI
137
Trexquant Investment
Connecticut
$462K +$428K +10,302 New
TG
138
TCW Group
California
$457K +$423K +10,184 New
ERSOT
139
Employees Retirement System of Texas
Texas
$449K – – –
HCM
140
Highbridge Capital Management
New York
$444K -$148K -3,559 -26%
CGH
141
Crossmark Global Holdings
Texas
$442K +$409K +9,849 New
PA
142
Profund Advisors
Maryland
$428K -$30.6K -736 -7%
ACI
143
AMP Capital Investors
Australia
$422K +$391K +9,400 New
FMT
144
First Mercantile Trust
Tennessee
$416K -$6.48K -156 -2%
Public Employees Retirement Association of Colorado
145
Public Employees Retirement Association of Colorado
Colorado
$413K – – –
FQ
146
First Quadrant
California
$399K -$1.7K -41 -0.5%
CSS
147
Cubist Systematic Strategies
Connecticut
$389K +$86.5K +2,082 +32%
Zurich Cantonal Bank
148
Zurich Cantonal Bank
Switzerland
$388K +$292K +7,017 +430%
FIM
149
Freedom Investment Management
Connecticut
$384K +$34.9K +841 +11%
EMG
150
Ellington Management Group
Connecticut
$372K +$345K +8,300 New
4 5
6
7 8

HAE Hedge Fund Activity: Q3 2017 in Review

207 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q3 2017, worth a combined $2.46B — up 12% from $2.19B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new HAE positions and 17 closed out — a net gain of 13 holders — while 77 added to existing stakes and 72 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $15.8M. The largest seller was Black Creek Investment Management, cutting an estimated $32.6M.

  • 207 institutional investors held Haemonetics (HAE) as of Q3 2017, up from 197 in Q2 2017.
  • Funds reported $2.46B of Haemonetics stock for Q3 2017, up 12% quarter-over-quarter.
  • 30 funds opened new Haemonetics positions in Q3 2017 and 17 closed out, a net change of +13 holders.
  • The largest Haemonetics buyer in Q3 2017 was Victory Capital Management, an estimated $15.8M added.
  • The largest Haemonetics seller in Q3 2017 was Black Creek Investment Management, an estimated $32.6M sold.

Based on aggregated 13F filings for Q3 2017.